InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Ullem Scott B., Chief Financial Officer. Officer active across 1 companies, notably Edwards Lifesciences Corp. In total, 14 disclosures have been recorded. The latest transaction was disclosed on 11 May 2026 — Levée d'options. Regulator: SEC (Form 4). All data is free.
Declarations14 total
019,830 shares0
Common Stock
SEC:0001225208-26-005133·
019,830 shares0
Common Stock
SEC:0001225208-26-005133:0·
€177,6201,953 shares@ €90.94740.0004% mcap29.8% of flow
Common Stock
SEC:0001225208-22-007142:0·
€73,627772 shares@ €95.37240.0001% mcap12.3% of flow
Common Stock
SEC:0001225208-22-006812:0·
015,488 shares0
Common Stock
SEC:0001225208-22-006582:0·
€29,771319 shares@ €93.32690.0001% mcap5.0% of flow
Common Stock
SEC:0001225208-22-002983:0·
017,193 shares0
Common Stock
SEC:0001225208-21-008301:0·
017,193 shares0
Common Stock
SEC:0001225208-21-008301·
€116,8661,570 shares@ €74.4370.0002% mcap74.1% of flow
Common Stock
SEC:0001225208-21-008057·
€116,8661,570 shares@ €74.4370.0002% mcap19.6% of flow
Common Stock
SEC:0001225208-21-008057:0·
€40,901538 shares@ €76.0240.0001% mcap25.9% of flow
Common Stock
SEC:0001225208-21-007975·
€40,901538 shares@ €76.0240.0001% mcap6.9% of flow
Common Stock
SEC:0001225208-21-007975:0·
05,100 shares0
Common Stock
SEC:0001225208-21-007706:0·
5,100 shares
Common Stock
SEC:0001225208-21-007706·
14 of 14 declarations
About Ullem Scott B.
Scott B. Ullem is the Chief Financial Officer at Edwards Lifesciences Corp. He is responsible for the financial management of the company, including financial planning, risk management, and financial strategy. With deep expertise in the field, he plays a crucial role in optimizing financial performance and making informed decisions to support the company's growth.
